Mark Carbeau is the CEO of BacterioScan. Secondary bacterial infections that are a key contributor to Covid-19 morality, but also are a perennial mainstay with at least 25,000 deaths each year in the US alone. Superbugs and resistance are a greater threat in this cycle than the virus alone, particularly in longer term health care settings. So we need to:
a) fix economic model for antibiotic development, and
b) advance diagnostic platforms to provide physicians answers before antibiotics. To treat sooner and treat appropriately. And the two needs should be linked
Create your
podcast in
minutes
It is Free